Etsuko Yamamoto Hattori (E Y Hattori)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 10

Top Topics

Transcription Factor

Smoking Cessation

Brain Metastases

Radiation Induced

Top Venues

AJNR. American journal of neuroradiology

Molecules and cells

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

T Sasagasako, Hisae Mori, Etsuko Yamamoto Hattori, Taichi Ikedo, Eika Hamano, K Shimonaga, Y Kushi, Koji Iihara, Hiroharu Kataoka
Radiation-Induced Changes Associated with Obliteration of Brain AVMs after Repeat Radiosurgery. AJNR. American journal of neuroradiology 44 (2) (2023)
T Sasagasako, Hisae Mori, Etsuko Yamamoto Hattori, Taichi Ikedo, Eika Hamano, K Shimonaga, Y Kushi, Koji Iihara, Hiroharu Kataoka
Radiation-Induced Changes Associated with Obliteration of Brain AVMs after Repeat Radiosurgery. AJNR. American journal of neuroradiology 44 (2) (2023)
T Sasagasako, Hisae Mori, Etsuko Yamamoto Hattori, Taichi Ikedo, Eika Hamano, K Shimonaga, Y Kushi, Koji Iihara, Hiroharu Kataoka
Radiation-Induced Changes Associated with Obliteration of Brain AVMs after Repeat Radiosurgery. AJNR. American journal of neuroradiology 44 (2) (2023)
T Sasagasako, Hisae Mori, Etsuko Yamamoto Hattori, Taichi Ikedo, Eika Hamano, K Shimonaga, Y Kushi, Koji Iihara, Hiroharu Kataoka
Radiation-Induced Changes Associated with Obliteration of Brain AVMs after Repeat Radiosurgery. AJNR. American journal of neuroradiology (2023)
Masamitsu Mikami, Tatsuya Masuda, Takuya Kanatani, Mina Noura, Katsutsugu Umeda, Hidefumi Hiramatsu, Hirohito Kubota, Tomoo Daifu, Atsushi Iwai, Etsuko Yamamoto Hattori, Kana Furuichi, Saho Takasaki, Sunao Tanaka, Yasuzumi Matsui, Hidemasa Matsuo, Masahiro Hirata, Tatsuki R Kataoka, Tatsutoshi Nakahata, Yasumichi Kuwahara, Tomoko Iehara, Hajime Hosoi, Yoichi Imai, Junko Takita, Hiroshi Sugiyama, Souichi Adachi, Yasuhiko Kamikubo
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors. Molecules and cells 45 (12) (2022)
Etsuko Yamamoto Hattori, Tatsuya Masuda, Yohei Mineharu, Masamitsu Mikami, Yukinori Terada, Yasuzumi Matsui, Hirohito Kubota, Hidemasa Matsuo, Masahiro Hirata, Tatsuki R Kataoka, Tatsutoshi Nakahata, Shuji Ikeda, Susumu Miyamoto, Hiroshi Sugiyama, Yoshiki Arakawa, Yasuhiko Kamikubo
Author Correction: A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice. Communications biology 5 (1) (2022)
Masamitsu Mikami, Tatsuya Masuda, Takuya Kanatani, Mina Noura, Katsutsugu Umeda, Hidefumi Hiramatsu, Hirohito Kubota, Tomoo Daifu, Atsushi Iwai, Etsuko Yamamoto Hattori, Kana Furuichi, Saho Takasaki, Sunao Tanaka, Yasuzumi Matsui, Hidemasa Matsuo, Masahiro Hirata, Tatsuki R Kataoka, Tatsutoshi Nakahata, Yasumichi Kuwahara, Tomoko Iehara, Hajime Hosoi, Yoichi Imai, Junko Takita, Hiroshi Sugiyama, Souichi Adachi, Yasuhiko Kamikubo
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors. Molecules and cells 45 (12) (2022)
Masamitsu Mikami, Tatsuya Masuda, Takuya Kanatani, Mina Noura, Katsutsugu Umeda, Hidefumi Hiramatsu, Hirohito Kubota, Tomoo Daifu, Atsushi Iwai, Etsuko Yamamoto Hattori, Kana Furuichi, Saho Takasaki, Sunao Tanaka, Yasuzumi Matsui, Hidemasa Matsuo, Masahiro Hirata, Tatsuki R Kataoka, Tatsutoshi Nakahata, Yasumichi Kuwahara, Tomoko Iehara, Hajime Hosoi, Yoichi Imai, Junko Takita, Hiroshi Sugiyama, Souichi Adachi, Yasuhiko Kamikubo
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors. Molecules and cells 45 (12) (2022)
Masamitsu Mikami, Tatsuya Masuda, Takuya Kanatani, Mina Noura, Katsutsugu Umeda, Hidefumi Hiramatsu, Hirohito Kubota, Tomoo Daifu, Atsushi Iwai, Etsuko Yamamoto Hattori, Kana Furuichi, Saho Takasaki, Sunao Tanaka, Yasuzumi Matsui, Hidemasa Matsuo, Masahiro Hirata, Tatsuki R Kataoka, Tatsutoshi Nakahata, Yasumichi Kuwahara, Tomoko Iehara, Hajime Hosoi, Yoichi Imai, Junko Takita, Hiroshi Sugiyama, Souichi Adachi, Yasuhiko Kamikubo
RUNX1-Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors. Molecules and cells 45 (12) (2022)
Etsuko Yamamoto Hattori, Tatsuya Masuda, Yohei Mineharu, Masamitsu Mikami, Yukinori Terada, Yasuzumi Matsui, Hirohito Kubota, Hidemasa Matsuo, Masahiro Hirata, Tatsuki R Kataoka, Tatsutoshi Nakahata, Shuji Ikeda, Susumu Miyamoto, Hiroshi Sugiyama, Yoshiki Arakawa, Yasuhiko Kamikubo
A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice. Communications biology 5 (1) (2022)